Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 17,500 shares at $1.56 ($28K) on 2021-12-30, disclosed to the SEC on 2022-01-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.60 | 1,000 | $2K | 5.8% |
| 2 | $1.57 | 2,700 | $4K | 15.4% |
| 3 | $1.56 | 6,800 | $11K | 38.6% |
| 4 | $1.58 | 7,000 | $11K | 40.2% |
| Total | $1.57 avg | 17,500 | $28K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |